Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 5, doi. 10.2337/diaclin.33.1.5
- By:
- Publication type:
- Article
Works matching IS 08918929 AND DT 2015 AND VI 33 AND IP 1
Results: 8
1
2
Cutaneous Manifestations of Diabetes Mellitus.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 40, doi. 10.2337/diaclin.33.1.40
- By:
- Publication type:
- Article
3
Continuing Medical Education for Promoting Shared Medical Visits in Diabetes Care.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 28, doi. 10.2337/diaclin.33.1.28
- By:
- Publication type:
- Article
4
Rare Presentations of Ketoacidosis: Diabetic Ketoalkalosis and Ketoacidosis Secondary to Fasting and Muscular Dystrophy.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
5
The Diabetes Attitudes, Wishes and Needs Second Study.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 32, doi. 10.2337/diaclin.33.1.32
- By:
- Publication type:
- Article
6
Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 14, doi. 10.2337/diaclin.33.1.14
- By:
- Publication type:
- Article
7
The Health Care Maze: How We Treat Our Elderly: One Man's Journey.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
8
Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment.
- Published in:
- Clinical Diabetes, 2015, v. 33, n. 1, p. 20, doi. 10.2337/diaclin.33.1.20
- By:
- Publication type:
- Article